Community/Retail

This medication, indicated for individuals with diabetes, will have a list price that is 50% lower than its current list price.

Many women are unaware of HIV pre-exposure prophylaxis (PrEP) but show a keen interest in spreading the word once they learn about the option, according a recent study in the journal Contraception.

Investigators from the CDC Human Papillomavirus (HPV) Vaccine Impact Monitoring Project (HPV-IMPACT) sought to determine whether HPV types 16 and 18, which are responsible for approximately 70% of cervical cancers worldwide, are also decreasing.

Analysis of care in a routine clinical practice setting show that 40-week treatment of biologic dupilumab (Dupixent, Sanofi-Regeneron) plus noncosmetic topical moisturizer (emollient) is associated with significantly improved symptoms and health-related quality of life (HRQoL) in particular patients with atopic dermatitis (AD).

A large retrospective study of patients with acne found no significant association between isotretinoin exposure and depression.

The recalled losartan potassium tablets made by Hetero Labs and distributed by Camber Pharmaceuticals contain the impurity, N-Nitroso-N-methyl-4-aminobutyric acid (NMBA), which is a known animal and potential human carcinogen.

Novo Nordisk is seeking approval for fast-acting insulin aspart (Fiasp) as a new mealtime insulin for children and adolescents with type 1 diabetes.

The agency urges the public to receive a vaccine if they have not already done so.

The drug's approval was based on 4 clinical studies evaluating the efficacy and safety of Adhansia XR in 883 people who met DSM-5 criteria for ADHD.

According to the agency, these drugs are potentially dangerous to consumers in the United States.

The research centers on CD8+ T cells, which can recognize and attack the influenza virus.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Blue Cross and Blue Shield of Texas is partnering with 11 Universities to study challenges that increase costs.

The new formulation will provide patients with a faster alternative for management of suspected myocardial infarction.

Indivior’s once-monthly schizophrenia treatment risperidone (Perseris) extended-release injectable suspension has launched in the United States.

According to the CDC, major interventions are in need among at-risk populations in order to reach a goal of 90% decrease of HIV infections in 10 years.

The CDC has declared immunizations one of the greatest health achievements of the 20th century, but vaccination rates among adults remain suboptimal.

Trastuzumab and hyaluronidase-oysk (Herceptin Hylecta, Genentech) is indicated for subcutaneous administration in certain patients with HER2-positive early and metastatic breast cancer.

IBSA Pharma’s levothyroxine sodium (Tirosint-SOL) oral solution is now available in the United States market for the treatment of hypothyroidism and pituitary thyrotropin suppression.

For this edition of Throwback Thursday, we look back in time at Jonas Salk and his research.

Amazon announced their acquisition of the online pharmacy PillPack, which prides itself on customer service by offering presorted medication, and home delivery, in a press release in June of 2018.

The controlled injection offers patients with plaque psoriasis the ease of self-injection.

Not according to Richard Koch in his book The 80/20 Principle: The Secret to Success by Achieving More with Less.

Ohio is arguably one of the states hardest hit by prescription drug abuse and the opioid epidemic.

Methylprednisolone Tablets had annual sales of approximately $114.3 million in the United States.

The higher dose is only approved for patients with ulcerative colitis, and not for RA.

A survey of sexually active women in the United States revealed that 29% experienced challenges in obtaining either a prescription or a refill for hormonal contraception.

Within the group of Spanish patients with ADHD, a specific variation of the LPHN3 gene increased by 40% the risk of nicotine dependence.

The new loteprednol etabonate ophthalmic gel formulation is expected to be available as a treatment option by April 2019.

The drug showed significant improvement on every primary and secondary endpoint in those who had failed treatment with surgery and/or systemic corticosteroids.